| Sunitinib | Axitinib | Pazopanib | Sorafenib | Everolimus | Temsirolimus | |
---|---|---|---|---|---|---|---|
SNU-228 | Control | 1.13 | 1.37 | 1.24 | 1.34 | 1.43 | 1.45 |
Resistant cells | 0.93 (0.82) | 1.02 (0.74) | 1.06 (0.85) | 1.18 (0.88) | 1.23 (0.86) | 1.23 (0.85) | |
Reversible | 0.94 (0.83) | 1.06 (0.77) | 0.93 (0.75) | 1.17 (0.87) | 1.24 (0.87) | 1.24 (0.86) | |
SNU-267 | Control | 1.17 | 1.38 | 1.42 | 1.36 | 1.33 | 1.35 |
Resistant cells | 1.05 (0.90) | 1.24 (0.90) | 1.27 (0.89) | 1.24 (0.91) | 1.23 (0.92) | 1.24 (0.92) | |
Reversible | 1.01 (0.86) | 1.22 (0.88) | 1.27 (0.89) | 1.23 (0.90) | 1.19 (0.89) | 1.23 (0.91) |